Literature DB >> 15251430

ING4 induces G2/M cell cycle arrest and enhances the chemosensitivity to DNA-damage agents in HepG2 cells.

Xin Zhang1, Lu-Sheng Xu, Zhi-Qin Wang, Ke-Sheng Wang, Na Li, Zhi-Hong Cheng, Shang-Zhi Huang, Dong-Zhi Wei, Ze-Guang Han.   

Abstract

The known members of inhibitor of growth (ING) gene family are considered as candidate tumor suppressor genes. ING4, a novel member of ING family, is recently reported to interact with tumor suppressor p53, p300 (a major component of histone acetyl transferase complexes), and p65(RelA) subunit of NF-kappaB. In this study, we investigated the cellular behaviors of HepG2 cells with exogenous ING4. Interestingly, the overexpression of ING4 negatively regulated the cell growth with significant G2/M arrest of cell cycle, and moreover, enhanced the cell apoptosis triggered by serum starvation in HepG2 cells. Furthermore, the exogenous ING4 could upregulate endogenous p21 and Bax in HepG2 cells, not in p53-deficient Saos-2 cells, suggesting that G2/M arrest induced by ING4 could be mediated by the increased p21 expression in a p53-dependent manner, although there is no significant increase of p53 expression in HepG2 cells. Moreover, HepG2 cells with exogenous ING4 could significantly increase cell death, as exposed to some DNA-damage agents, such as etoposide and doxorubicin, implying that ING4 could enhance chemosensitivity to certain DNA-damage agents in HepG2 cells.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15251430     DOI: 10.1016/j.febslet.2004.06.010

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  43 in total

1.  A dominant mutant allele of the ING4 tumor suppressor found in human cancer cells exacerbates MYC-initiated mouse mammary tumorigenesis.

Authors:  Suwon Kim; Alana L Welm; J Michael Bishop
Journal:  Cancer Res       Date:  2010-05-25       Impact factor: 12.701

2.  ING4 enhances paclitaxel's effect on colorectal cancer growth in vitro and in vivo.

Authors:  Liyu Cao; Shunhua Chen; Cong Zhang; Cong Chen; Nana Lu; Yan Jiang; Yongping Cai; Yu Yin; Jianming Xu
Journal:  Int J Clin Exp Pathol       Date:  2015-03-01

3.  Deletion of the inhibitor of growth 4 (ING4) tumor suppressor gene is prevalent in human epidermal growth factor 2 (HER2)-positive breast cancer.

Authors:  Coya Tapia; Inti Zlobec; Sandra Schneider; Ergin Kilic; Uwe Güth; Lukas Bubendorf; Suwon Kim
Journal:  Hum Pathol       Date:  2011-02-11       Impact factor: 3.466

4.  ING4 is negatively correlated with microvessel density in colon cancer.

Authors:  Chun Lou; Shixiong Jiang; Xinggang Guo; Xin-shu Dong
Journal:  Tumour Biol       Date:  2012-09-28

5.  Downregulation of inhibitor of growth 3 is correlated with tumorigenesis and progression of hepatocellular carcinoma.

Authors:  Meiling Lu; Fei Chen; Qinwan Wang; Kesheng Wang; Qiuhui Pan; Xin Zhang
Journal:  Oncol Lett       Date:  2012-04-19       Impact factor: 2.967

6.  Tumor suppressor ING4 overexpression contributes to proliferation and invasion inhibition in gastric carcinoma by suppressing the NF-κB signaling pathway.

Authors:  Shijie Li; Tianli Fan; Hongtao Liu; Jiangtao Chen; Changjiang Qin; Xuequn Ren
Journal:  Mol Biol Rep       Date:  2013-09-22       Impact factor: 2.316

Review 7.  ING proteins as potential anticancer drug targets.

Authors:  M Unoki; K Kumamoto; C C Harris
Journal:  Curr Drug Targets       Date:  2009-05       Impact factor: 3.465

Review 8.  The ING gene family in the regulation of cell growth and tumorigenesis.

Authors:  Andrew H Coles; Stephen N Jones
Journal:  J Cell Physiol       Date:  2009-01       Impact factor: 6.384

9.  Curcumin induces G2/M cell cycle arrest in a p53-dependent manner and upregulates ING4 expression in human glioma.

Authors:  Enyu Liu; Jing Wu; Weidong Cao; Jianning Zhang; Weiping Liu; Xiaofan Jiang; Xiang Zhang
Journal:  J Neurooncol       Date:  2007-06-27       Impact factor: 4.130

10.  Frankincense oil derived from Boswellia carteri induces tumor cell specific cytotoxicity.

Authors:  Mark Barton Frank; Qing Yang; Jeanette Osban; Joseph T Azzarello; Marcia R Saban; Ricardo Saban; Richard A Ashley; Jan C Welter; Kar-Ming Fung; Hsueh-Kung Lin
Journal:  BMC Complement Altern Med       Date:  2009-03-18       Impact factor: 3.659

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.